ALDER BIOPHARMACEUTICALS INC - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - April 25, 2014

Attached files

file filename
S-1/A - S-1/A - ALDER BIOPHARMACEUTICALS INCd657876ds1a.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex11.htm
EX-10.24 - MASTER PRODUCT DEVELOPMENT & CLINICAL SUPPLY AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex1024.htm
EX-5.1 - OPINION OF COOLEY LLP - ALDER BIOPHARMACEUTICALS INCd657876dex51.htm
EX-4.2 - AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTORS' RIGHST AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex42.htm
EX-3.3 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - ALDER BIOPHARMACEUTICALS INCd657876dex33.htm
EX-10.5 - FORM OF STOCK OPTION GRANT NOTICE AND OPTION AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex105.htm
EX-10.4 - 2014 EQUITY INCENTIVE PLAN - ALDER BIOPHARMACEUTICALS INCd657876dex104.htm
EX-10.25 - 1ST AMENDMENT TO MASTER PRODUCT DEVELOPMENT & CLINICAL SUPPLY AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex1025.htm
EX-3.5 - FORM OF AMENDED AND RESTATED BYLAWS - ALDER BIOPHARMACEUTICALS INCd657876dex35.htm
EX-10.1 - FORM OF INDEMNITY AGREEMENT BETWEEN THE ALDER BIOPHARMACEUTICALS, INC - ALDER BIOPHARMACEUTICALS INCd657876dex101.htm
EX-3.2 - CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - ALDER BIOPHARMACEUTICALS INCd657876dex32.htm
EX-10.7 - FORM OF EXECUTIVE SEVERANCE BENEFIT PLAN - ALDER BIOPHARMACEUTICALS INCd657876dex107.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Alder BioPharmaceuticals, Inc. of our report dated March 17, 2014, except for the effects of the reverse stock split described in the last paragraph of Note 1 as to which the date is April 24, 2014, relating to the financial statements of Alder BioPharmaceuticals, Inc., which appear in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

April 24, 2014

ALDER BIOPHARMACEUTICALS INC Reports

Also read